Want to see IN:VAISHALI full AI Analyst Report?
Vaishali Pharma Ltd. (VAISHALI) Ratios
Vaishali Pharma Ltd. Ratios
IN:VAISHALI's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, IN:VAISHALI's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.34 | 2.61 | 2.25 | 2.27 | 1.47 |
| Quick Ratio | 2.27 | 2.49 | 2.24 | 2.17 | 1.46 |
| Cash Ratio | 0.03 | 0.05 | 0.04 | 0.02 | 0.02 |
| Solvency Ratio | 0.09 | 0.03 | 0.03 | 0.19 | 0.08 |
| Operating Cash Flow Ratio | 0.00 | -0.49 | 0.02 | 0.03 | 0.03 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -2.52 | 0.09 | 0.13 | 0.07 |
| Net Current Asset Value | $ 586.89M | $ 595.55M | $ 374.03M | $ 343.05M | $ 211.55M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.15 | 0.11 | 0.17 | 0.19 | 0.25 |
| Debt-to-Equity Ratio | 0.27 | 0.19 | 0.31 | 0.36 | 0.79 |
| Debt-to-Capital Ratio | 0.21 | 0.16 | 0.24 | 0.27 | 0.44 |
| Long-Term Debt-to-Capital Ratio | 0.08 | 0.06 | 0.08 | 0.11 | 0.11 |
| Financial Leverage Ratio | 1.79 | 1.69 | 1.87 | 1.95 | 3.10 |
| Debt Service Coverage Ratio | 0.19 | 0.31 | 0.26 | 0.85 | 0.34 |
| Interest Coverage Ratio | 1.79 | -0.25 | 0.30 | 5.47 | 2.50 |
| Debt to Market Cap | 0.29 | 0.70 | 0.68 | 0.84 | 2.97 |
| Interest Debt Per Share | 1.60 | 9.60 | 12.39 | 15.21 | 22.09 |
| Net Debt to EBITDA | 4.24 | 3.25 | 3.80 | 1.25 | 2.27 |
| Profitability Margins | |||||
| Gross Profit Margin | 9.32% | 10.39% | 11.18% | 18.54% | 10.60% |
| EBIT Margin | 3.23% | 2.84% | 3.09% | 15.58% | 10.80% |
| EBITDA Margin | 3.78% | 3.33% | 3.68% | 16.31% | 11.40% |
| Operating Profit Margin | 3.23% | -0.40% | 0.78% | 17.73% | 8.20% |
| Pretax Profit Margin | 5.07% | 1.24% | 1.07% | 12.70% | 7.56% |
| Net Profit Margin | 3.83% | 0.83% | 0.83% | 9.48% | 5.31% |
| Continuous Operations Profit Margin | 3.83% | 0.83% | 0.83% | 9.48% | 5.31% |
| Net Income Per EBT | 75.45% | 66.68% | 77.63% | 74.66% | 70.24% |
| EBT Per EBIT | 157.09% | -308.97% | 138.39% | 71.61% | 92.15% |
| Return on Assets (ROA) | 3.38% | 0.74% | 0.90% | 8.37% | 4.93% |
| Return on Equity (ROE) | 6.03% | 1.26% | 1.68% | 16.29% | 15.27% |
| Return on Capital Employed (ROCE) | 4.68% | -0.57% | 1.43% | 26.38% | 20.94% |
| Return on Invested Capital (ROIC) | 3.00% | -0.34% | 0.92% | 16.63% | 9.22% |
| Return on Tangible Assets | 3.40% | 0.75% | 0.91% | 8.46% | 4.98% |
| Earnings Yield | 6.56% | 4.79% | 3.90% | 40.51% | 57.63% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.14 | 2.12 | 1.39 | 1.06 | 1.07 |
| Payables Turnover | 4.66 | 3.27 | 3.84 | 3.04 | 2.24 |
| Inventory Turnover | 29.00 | 18.45 | 195.98 | 17.93 | 100.96 |
| Fixed Asset Turnover | 94.22 | 85.32 | 59.29 | 38.75 | 83.92 |
| Asset Turnover | 0.88 | 0.90 | 1.08 | 0.88 | 0.93 |
| Working Capital Turnover Ratio | 1.69 | 1.87 | 2.10 | 2.14 | 3.26 |
| Cash Conversion Cycle | 104.60 | 80.33 | 168.49 | 243.00 | 180.75 |
| Days of Sales Outstanding | 170.37 | 172.19 | 261.72 | 342.78 | 340.27 |
| Days of Inventory Outstanding | 12.58 | 19.78 | 1.86 | 20.36 | 3.62 |
| Days of Payables Outstanding | 78.36 | 111.65 | 95.10 | 120.14 | 163.13 |
| Operating Cycle | 182.96 | 191.98 | 263.59 | 363.14 | 343.89 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | -13.20 | 0.63 | 0.97 | 1.25 |
| Free Cash Flow Per Share | 0.00 | -13.41 | 0.21 | 0.70 | 0.43 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -63.79 | 7.27 | 3.63 | 1.52 |
| Capital Expenditure Coverage Ratio | 0.00 | -63.79 | 7.27 | 3.63 | 1.52 |
| Operating Cash Flow Coverage Ratio | 0.00 | -1.55 | 0.06 | 0.07 | 0.06 |
| Operating Cash Flow to Sales Ratio | 0.00 | -0.20 | 0.01 | 0.02 | 0.02 |
| Free Cash Flow Yield | 0.00% | -115.78% | 1.47% | 4.80% | 6.50% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 15.25 | 20.68 | 25.63 | 2.47 | 1.74 |
| Price-to-Sales (P/S) Ratio | 0.58 | 0.17 | 0.21 | 0.23 | 0.09 |
| Price-to-Book (P/B) Ratio | 0.92 | 0.26 | 0.43 | 0.40 | 0.26 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 0.00 | -0.86 | 67.97 | 20.83 | 15.39 |
| Price-to-Operating Cash Flow Ratio | 0.00 | -0.88 | 22.84 | 15.10 | 5.29 |
| Price-to-Earnings Growth (PEG) Ratio | -0.36 | -2.14 | -0.28 | 0.04 | 0.01 |
| Enterprise Value Multiple | 19.68 | 8.42 | 9.61 | 2.69 | 3.08 |
| Enterprise Value | 809.73M | 277.56M | 304.62M | 305.07M | 266.31M |
| EV to EBITDA | 19.68 | 8.42 | 9.61 | 2.69 | 3.08 |
| EV to Sales | 0.74 | 0.28 | 0.35 | 0.44 | 0.35 |
| EV to Free Cash Flow | 0.00 | -1.41 | 112.37 | 38.99 | 58.69 |
| EV to Operating Cash Flow | 0.00 | -1.43 | 37.76 | 28.26 | 20.20 |
| Tangible Book Value Per Share | 5.25 | 43.47 | 33.05 | 35.51 | 24.26 |
| Shareholders’ Equity Per Share | 5.31 | 44.10 | 33.69 | 36.28 | 24.99 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.25 | 0.33 | 0.22 | 0.25 | 0.30 |
| Revenue Per Share | 8.36 | 67.27 | 67.84 | 62.35 | 71.89 |
| Net Income Per Share | 0.32 | 0.56 | 0.57 | 5.91 | 3.82 |
| Tax Burden | 0.75 | 0.67 | 0.78 | 0.75 | 0.70 |
| Interest Burden | 1.57 | 0.44 | 0.35 | 0.81 | 0.70 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.06 | 0.11 | 0.01 | 0.01 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.00 | -23.78 | 1.12 | 0.12 | 0.23 |
Currency in INR
